G 
Grown Rogue International GRIN.CN · CAD
Health Care · Canadian Securities Exchange · 🇨🇦 Canada
0.48
+2.13%
Close of 9 Nov 2026, in CAD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$27.0m
FY2015FY2024
Net income
−$11.3m
FY2015FY2024
Free cash flow
$5.4m
FY2015FY2024
Shareholders' equity
$14.6m
FY2015FY2024
Income statement
Fiscal years
| FY2024 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $27.0m | $23.4m | $17.8m | $9.4m | $4.2m | $3.9m | — | $15,200 | — |
| Research and development | — | — | — | — | — | — | — | $228,900 | $117,400 |
| Operating income | $1.7m | $4.5m | $1.9m | $777,600 | −$998,100 | −$4.5m | −$374,500 | −$2.0m | −$906,600 |
| Net income | −$11.3m | −$533,000 | $447,500 | −$2.4m | −$2.3m | −$9.3m | −$377,500 | −$1.5m | −$9.9m |
| Diluted earnings per share | -0.05 | -0.00 | 0.00 | -0.02 | -0.03 | -0.13 | -0.10 | -0.81 | -6.67 |
Balance sheet
At each fiscal year end
| FY2024 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $43.3m | $30.2m | $16.4m | $14.2m | $3.8m | $2.9m | $24,500 | $30,700 | $352,800 |
| Cash and short-term investments | $4.7m | $8.9m | $1.6m | $1.1m | $217,800 | $74,900 | $21,400 | $800 | $329,000 |
| Total liabilities | $28.8m | $18.6m | $9.4m | $9.1m | $4.7m | $4.4m | $616,500 | $387,400 | $857,800 |
| Debt | $8.4m | $6.7m | $4.9m | $4.6m | $2.7m | $2.3m | — | — | — |
| Shareholders' equity | $14.6m | $11.6m | $6.9m | $5.1m | −$911,600 | −$1.4m | −$592,000 | −$356,600 | −$505,000 |
| Shares outstanding | 209m | 173m | 169m | 135m | 91m | 71m | 4m | 2m | 1m |
Cash flow
Fiscal years
| FY2024 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $7.1m | $5.7m | $2.0m | −$238,500 | −$292,800 | −$3.4m | −$38,000 | −$461,500 | −$320,700 |
| Capital spending | −$1.7m | −$1.5m | −$1.1m | −$2.0m | −$557,800 | −$217,100 | — | — | — |
| Free cash flow | $5.4m | $4.3m | $892,900 | −$2.3m | −$850,600 | −$3.6m | −$38,000 | −$461,500 | −$320,700 |
Latest quarters
By quarter end
| Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | Jun 2024 | Mar 2024 | Oct 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.4m | $5.6m | $5.6m | $5.7m | $7.0m | $7.7m | $6.7m | $6.5m |
| Operating income | −$1.0m | −$841,600 | −$532,000 | −$1.1m | $444,400 | $843,000 | $1.5m | $1.3m |
| Net income | $2.7m | $1.3m | $997,500 | $1.4m | −$798,000 | −$7.7m | −$4.2m | −$2.1m |
| Diluted earnings per share | 0.01 | 0.01 | — | 0.01 | — | -0.04 | -0.02 | -0.01 |
| Total assets | $55.9m | $48.1m | $48.6m | $43.3m | $41.3m | $38.5m | $38.7m | $30.2m |
| Cash and short-term investments | $13.1m | $9.3m | $6.2m | $4.7m | $5.6m | $7.5m | $9.5m | $8.9m |
| Debt | $14.8m | $11.1m | $11.2m | $5.5m | $5.2m | $3.3m | $3.6m | $4.6m |
| Shareholders' equity | $30.7m | $27.4m | $19.0m | $14.6m | $11.9m | $10.4m | $13.7m | $11.6m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 15.0% | 44.8% | 87.6% |
| Operating income | -3.6% | — | 27.2% |
| Net income | — | 37.7% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 6.8% | 11.7% | 9.6% | — |
| Net margin | -34.8% | -15.0% | -18.1% | — |
Valuation history
At each fiscal year end
| FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -12.4 | 91.4 | -34.0 | 31.4 | -4.7 | -2.9 | -2.0 | -1.0 | -0.0 |
| Price to sales | 5.2 | 16.1 | 0.8 | 0.8 | 1.2 | 1.5 | 4.8 | — | 0.6 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 1.4-to-1 reverse split · 26 Nov 2018
- 10-to-1 reverse split · 29 May 2017
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.